F. Hoffmann-La Roche AG
F. Hoffmann-La Roche AG, commonly known as Roche, is a leading global healthcare company headquartered in Basel, Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, focusing on innovative solutions for oncology, immunology, infectious diseases, and personalised medicine. With a strong presence in Europe, North America, and Asia, Roche is renowned for its commitment to research and development, boasting a robust portfolio of core products, including groundbreaking biologics and diagnostic tools. The company’s unique approach to integrating pharmaceuticals and diagnostics sets it apart in the market, enabling tailored treatment options for patients. Roche's notable achievements include being consistently ranked among the top pharmaceutical companies worldwide, reflecting its dedication to advancing healthcare and improving patient outcomes.
DitchCarbon Score
How does F. Hoffmann-La Roche AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
F. Hoffmann-La Roche AG's score of 55 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
F. Hoffmann-La Roche AG's reported carbon emissions
F. Hoffmann-La Roche AG, headquartered in Switzerland (CH), reported significant carbon emissions in 2016, totalling approximately 326,001,000 kg CO2e for Scope 1, 320,860,000 kg CO2e for Scope 2 (market-based), and 209,660,000 kg CO2e for Scope 3 emissions related to business travel. The company has set ambitious mid-term goals to reduce energy consumption from Scope 1 and Scope 2 sources per employee by 15% by 2025, reflecting a commitment to improving operational efficiency and reducing its carbon footprint. The emissions data for 2015 and 2014 show a trend of high emissions, with Scope 1 emissions at 384,421,000 kg CO2e and 362,582,000 kg CO2e, respectively. This indicates a need for ongoing efforts to manage and reduce emissions across all scopes. The data is cascaded from Roche Holding AG, the parent company, which also influences the climate initiatives and targets set by F. Hoffmann-La Roche AG. Overall, Roche's commitment to reducing emissions is evident through its specific reduction targets and the focus on energy efficiency within its facilities. The company is actively working towards a more sustainable future while addressing its carbon emissions comprehensively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | |
|---|---|---|---|---|
| Scope 1 | 403,136,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 418,214,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 188,924,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
F. Hoffmann-La Roche AG is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
